Results from the UPITA-Colitis Registry on the Effectiveness and Safety of Upadacitinib in the Induction phase in Patients with Ulcerative Colitis

被引：0

作者：

Caballero Mateos, A. M. ^{[1
]}

Gonzalez-Parra, A. C. ^{[2
]}

Gutierrez-Holanda, C. ^{[3
]}

Trapero-Martinez, A. M. ^{[4
]}

Hernandez-Martinez, A. ^{[5
]}

Rojas-Feria, M. ^{[6
]}

Martin-Rodriguez, M. D. M. ^{[7
]}

Rodriguez-Gonzalez, F. J. ^{[8
]}

Saldana, L. ^{[9
]}

Benitez, J. M. ^{[10
]}

Gomez-Delgado, E. ^{[11
]}

Miras, L. ^{[12
]}

Gonzalez, J. ^{[13
]}

Mata, F. J. ^{[14
]}

Olmedo-Martin, R., V ^{[15
]}

GATE, II

机构：

[1] Santa Ana Hosp, Gastroenterol, Motril Granada, Spain

[2] Virgen Macarena Univ Hosp, Gastroenterol, Seville, Spain

[3] San Cecilio Universityl Hosp, Gastroenterol, Granada, Spain

[4] Univ Hosp, Gastroenterol, Jaen, Spain

[5] Torrecardenas Univ Hosp, Gastroenterol, Almeria, Spain

[6] Virgen Rocio Univ Hosp, Gastroenterol, Seville, Spain

[7] Virgen Nieves Univ Hosp, Gastroenterol, Granada, Spain

[8] Virgen Victoria Univ Hosp, Gastroenterol, Malaga, Spain

[9] Costa Sol Hosp, Gastroenterol, Marbella, Spain

[10] Reina Sofia Univ Hosp, Gastroenterol, Cordoba, Spain

[11] Juan Ramon Jimenez Hosp, Gastroenterol, Huelva, Spain

[12] El Poniente Hosp, Gastroenterol, El Ejido, Sri Lanka

[13] Inmaculada Hosp, Gastroenterol, Huercal Overa, Spain

[14] Puerto Real Hosp, Gastroenterol, Puerto Real, Spain

[15] Reg Hosp, Gastroenterol, Malaga, Spain

来源：

JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷

关键词：

D O I：

10.1093/ecco-jcc/jjae190.1284

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P1110

引用

页码：i2042 / i2044

页数：3

共 50 条

[31] Real life Effectiveness and safety of an induction treatment with tofacitinib in patients with Ulcerative Colitis: First results of the French TOFAST cohort
Fumery, M.
Bouhnik, Y.
Faure, P.
Bouzidi, A.
Brault, Y.
Peyrin-Biroulet, L.
Laharie, D.
JOURNAL OF CROHNS & COLITIS, 2023, 17 : 580 - 581
[32] Impact of corticosteroid usage on efficacy and safety outcomes in patients receiving upadacitinib for Ulcerative Colitis
Raine, T.
Ishiguro, Y.
Rubin, D.
Finney-Hayward, T.
Dapo, I.
Phillips, C.
Cheng, E.
Targownik, L.
Loftus-, E. V., Jr.
JOURNAL OF CROHNS & COLITIS, 2022, 16 : I089 - I090
[33] Comparative effectiveness and safety of infliximab and adalimumab in patients with ulcerative colitis
Singh, S.
Heien, H. C.
Sangaralingham, L. R.
Schilz, S. R.
Kappelman, M. D.
Shah, N. D.
Loftus, E. V.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (09) : 994 - 1003
[34] EFFICACY AND SAFETY OF GOLIMUMAB INDUCTION FOR MODERATE TO SEVERE ULCERATIVE COLITIS IN THE UNITED KINGDOM: RESULTS FROM THE GO-COLITIS
Probert, C.
Gaya, D.
Hamlin, P. J.
Irving, P.
Sebastian, S.
Gillespie, G.
Tate, H.
Wheeler, C.
GUT, 2017, 66 : A8 - A8
[35] IMPACT OF CORTICOSTEROID USAGE ON EFFICACY AND SAFETY OUTCOMES IN PATIENTS RECEIVING UPADACITINIB FOR ULCERATIVE COLITIS
Raine, Tim
Ishiguro, Yoh
Rubin, David T.
Finney-Hayward, Tricia K.
Ilo, Dapo
Philips, Charles
Chong, Erica
Targownik, Laura E.
Loftus, Edward V.
GASTROENTEROLOGY, 2022, 162 (07) : S975 - S976
[36] Upadacitinib for Induction of Remission in Pediatric Ulcerative Colitis: An International Multicenter Study
Yerushalmy-Feler, Anat
Spencer, Elizabeth A.
Dolinger, Michael T.
Suskind, David L.
Mitrova, Katarina
Hradsky, Ondrej
Conrad, Maire A.
Kelsen, Judith R.
Uhlig, Holm H.
Tzivinikos, Christos
Ancona, Silvana
Wlazlo, Magdalena
Hackl, Lukas
Shouval, Dror S.
Bramuzzo, Matteo
Urlep, Darja
Olbjorn, Christine
D'Arcangelo, Giulia
Pujol-Muncunill, Gemma
Yogev, Dotan
Kang, Ben
Gasparetto, Marco
Rungo, Christine
Kolho, Kaija-Leena
Hojsak, Iva
Norsa, Lorenzo
Rinawi, Firas
Sansotta, Naire
Magen Rimon, Ramit
Granot, Maya
Scarallo, Luca
Trindade, Eunice
Velasco Rodriguez-Belvis, Marta
Turner, Dan
Cohen, Shlomi
JOURNAL OF CROHNS & COLITIS, 2024,
[37] Upadacitinib for induction of remission in pediatric Ulcerative Colitis: An international multicenter study
Yerushalmy-Feler, A.
Spencer, E. A.
Dolinger, M. T.
Suskind, D. L.
Mitrova, K.
Hradsky, O.
Conrad, M. A.
Kelsen, J. R.
Uhlig, H. H.
Tzivinikos, C.
Ancona, S.
Wlazlo, M.
Hackl, L.
Shouval, D. S.
Bramuzzo, M.
Urlep, D.
Olbjorn, C.
D'Arcangelo, G.
Pujol-Muncunill, G.
Yogev, D.
Kang, B.
Gasparetto, M.
Rungo, C.
Kolho, K. L.
Hojsak, I
Norsa, L.
Rinawi, F.
Sansotta, N.
Rimon, R. Magen
Granot, M.
Scarallo, L.
Trindade, E.
Rodriguez-Belvis, M. Velasco
Turner, D.
Cohen, S.
JOURNAL OF CROHNS & COLITIS, 2025, 19 : i182 - i183
[38] THE EFFECT OF TOFACITINIB ON SERUM LIPIDS AND CARDIOVASCULAR SAFETY IN PATIENTS WITH ULCERATIVE COLITIS - RESULTS FROM THE TOFACITINIB ULCERATIVE COLITIS CLINICAL PROGRAM
Sands, Bruce E.
Taub, Pam R.
Feagan, Brian G.
Armuzzi, Alessandro
Friedman, Gary S.
Moscariello, Michele
Lawendy, Nervin
Pedersen, Ronald D.
Chan, Gary
Nduaka, Chudy I.
Quirk, Daniel
Salese, Leonardo
Su, Chinyu
GASTROENTEROLOGY, 2018, 154 (06) : S380 - S380
[39] The effect of tofacitinib on serum lipids and cardiovascular safety in patients with ulcerative colitis: results from the tofacitinib ulcerative colitis clinical programme
Sands, B. E.
Taub, P. R.
Feagan, B. G.
Armuzzi, A.
Friedman, G. S.
Moscariello, M.
Lawendy, N.
Pedersen, R. D.
Chan, G.
Nduaka, C. I.
Quirk, D.
Salese, L.
Su, C.
JOURNAL OF CROHNS & COLITIS, 2018, 12 : S23 - S23
[40] Real-world efficacy and safety of filgotinib in ulcerative colitis: results from the ENEIDA registry
Rodriguez-Lago, I
Cudero, L.
Pascual, C. Martinez
Minguez, A.
Ferreiro-Iglesias, R.
Arranz, L.
Royo, A. M.
Martin-Rodriguez, D.
Mejias, M. D. L. a
Calafat, M.
Calvo, M.
Gargallo-Puyuelo, C. J.
Granja, A.
Santos-Fernandez, J.
Ucha, P.
Ceballos, D.
Martin-Arranz, M. D.
Ferrer, I
Ramos, L.
Almela, P.
Fernandez-Clotet, A.
Garcia-Bosch, O.
Huguet, J. M.
Lozano, M. L.
Riestra, S.
Sese, E.
Torres, G.
Trapero, A. M.
Varela, P.
Domenech, E.
Barreiro-de Acosta, M.
GETECCU
JOURNAL OF CROHNS & COLITIS, 2025, 19 : I1620 - I1620

← 1 2 3 4 5 →